                         SEQUENCE LISTING

<110>  The Government of the United States of America as 
       Represented by the Secretary, Department of Health and Human 
       Services
       Wood, Bradford J.
       Dreher, Matthew
       Negussie, Ayele H.
 
<120>  CYCLIZED NGR PEPTIDE COMPOUNDS, COMPOSITIONS, AND METHODS OF 
       THEIR USE

<130>  NIHA-0426 (E-147-2008/0-PCT-02)

<150>  US 61/074,864
<151>  2008-06-23

<150>  US 61/106,722
<151>  2008-10-20

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lys or modified Lys where C substituted w/(CH2)4NR12R14, where 
       R12 = H or C1-6 alkyl; R14 = H, C1-6 alkyl, amino protecting 
       group, or diagnostic moiety; N substituted w/H or C1-6 alkyl

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Asn or modified Asn where C substituted w/CH2C(=O)NR12R15, where 
       R12 = H or C1-6 alkyl; R15 = H, C1-6 alkyl, or amino protecting 
       group; N substituted w/H or C1-6 alkyl

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Gly or modifyed Gly where C substituted w/H or C1-6 alkyl; N 
       substituted w/H or C1-6 alkyl

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Arg or modified Arg where C substituted w/(CH2)3NHC(R12R14) 
       (=N+R12R1, where R12=H or C1-6 alkyl; R14=H, C1-6 alkyl, amino 
       protecting group, or diagnostic moiety; R16=H, C1-6 alkyl, or 
       guanidino-protecting group; N substituted w/H or C1-6 alkyl

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Glu or modified Glu where both backbone C substituted w/H or C1-6
       alkyl; N substituted w/H or C1-6 alkyl

<400>  1

Lys Asn Gly Arg Glu 
1               5   


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lys is labeled with Oregon Green dye

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Linkage to make cyclic is between Lys and Glu

<400>  2

Lys Asn Gly Arg Glu 
1               5   


<210>  3
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Linkage to make cyclic is between Lys and Glu

<400>  3

Lys Asn Gly Arg Glu 
1               5   


<210>  4
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  4

Lys Asn Gly Arg Glu 
1               5   


